Supplemental material
Journal of Dermatological Treatment
Volume 33, 2022 - Issue 1
Review Articles
Indirect comparisons of ixekizumab versus three interleukin-23 p19 inhibitors in patients with moderate-to-severe plaque psoriasis – efficacy findings up to week 12
, , , , , 
, & show all
Saxon D. Smithc Discipline of Dermatology, Northern Sydney Medical School, University of Sydney, Sydney, NSW, Australia;d Department of Dermatology, Royal North Shore Hospital, St Leonards, NSW, Australiahttps://orcid.org/0000-0003-0995-4372View further author information
https://orcid.org/0000-0003-0995-4372View further author information, Yuval Ramote Department of Dermatology, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Jerusalem, Israelhttps://orcid.org/0000-0002-8606-8385View further author information
https://orcid.org/0000-0002-8606-8385View further author information & show all